Effect of triple versus dual antiplatelet therapy in patients undergoing percutaneous intervention: systematic review and meta-analysis with GRADE system
{{output}}
Introduction: To lower major adverse cardiac events following percutaneous coronary intervention (PCI), antiplatelet therapy should be continued. We evaluated triple antiplatelet therapy (TAT) versus standard dual treatment (DAT)... ...
